Stanley-Laman Group’s Qiagen QGEN Stock Holding History

Stanley-Laman Group’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-6,405	Closed	-$224K	–	289
2019 Q3	$224K	Buy	+6,405	New	+$246K	0.06%	251

Other funds holding QGEN

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Stanley-Laman Group's QGEN Position: Q4 2019 in Review

Stanley-Laman Group sold out of Qiagen (QGEN) in Q4 2019, closing a stake of 6,405 shares — an estimated $224K sold.

Stanley-Laman Group first reported a position in QGEN in Q3 2019 and held it in 1 quarter. The position peaked at $224K in Q3 2019. 296 funds tracked by Wall St. Rank hold QGEN as of Q4 2019.

Stanley-Laman Group reported no remaining Qiagen position as of Q4 2019 after selling out during the quarter.
Stanley-Laman Group sold 6,405 Qiagen shares in Q4 2019, an estimated $224K.
Stanley-Laman Group first reported a position in Qiagen in Q3 2019 and held it in 1 quarter.
Stanley-Laman Group's Qiagen position peaked at $224K in Q3 2019.
296 funds tracked by Wall St. Rank held Qiagen as of Q4 2019.

Based on Stanley-Laman Group's 13F filing for Q4 2019, filed 4 Feb 2020.